Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.639, 2011-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Which long-acting 2-agonist is best? Formoterol vs salmeterol
Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. :
Access to resources
Recommend
Preventing CMV infection - which strategy's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
Reducing the burden of congenital syphilis: which options best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. :
Measuring indirect costs: which method's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. :
TB drug susceptibility testing strategies: which is best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. :